Chemistry: analytical and immunological testing – Lipids – triglycerides – cholesterol – or lipoproteins
Reexamination Certificate
2005-03-22
2005-03-22
Wang, Shengjun (Department: 1617)
Chemistry: analytical and immunological testing
Lipids, triglycerides, cholesterol, or lipoproteins
C424S009100, C436S097000, C436S071000
Reexamination Certificate
active
06869802
ABSTRACT:
A new method for predicting the risk of coronary artery disease (CAD) is disclosed. The method uses a ratio made up of the levels of an individuals LDL-cholesterol (LDL-C), HDL-cholesterol (HDL-C) and serum total bilirubin (bilirubin). The ratio, using a weighted value for bilirubin, is LDL-C/(HDL-C+bilirubin).
REFERENCES:
patent: 5380667 (1995-01-01), Schwertner
Webster's II Dictionary, New Riverside University Dictionary, 1994, p. 249.*
Kannel et al (Ann. Intern. Med. 90:85-92, 1979).
Fischer, Jr. Joseph R.
Schwertner Harvey A.
AFMCLO/JAZ
Sharareh Shahnam
Sinder Fredric L.
The United States of America as represented by the Secretary of
Wang Shengjun
LandOfFree
Combined cholesterol and bilirubin tests as risk predictors... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Combined cholesterol and bilirubin tests as risk predictors..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Combined cholesterol and bilirubin tests as risk predictors... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3437136